Valuation: Beijing SL Pharmaceutical Co., Ltd.

Market Cap 5.29B 792M 711M 649M 593M 1.12B 74.47B 1.15B 7.83B 3.12B 39.74B 2.97B 2.91B 125B P/E 2024
-107x
P/E 2025 -21.7x
Enterprise Value 4.15B 621M 557M 509M 465M 876M 58.41B 904M 6.14B 2.45B 31.17B 2.33B 2.28B 98.39B EV / Sales 2024
8.62x
EV / Sales 2025 10.3x
Free-Float
59.02%
Yield 2024
0.27%
Yield 2025 0.14%
1 day-1.53%
1 week+3.41%
Current month+3.41%
1 month-10.43%
3 months-9.49%
6 months-20.40%
Current year-30.12%
1 week 4.93
Extreme 4.93
5.25
1 month 4.93
Extreme 4.93
5.85
Current year 4.81
Extreme 4.81
9.4
1 year 4.81
Extreme 4.81
9.4
3 years 4.81
Extreme 4.81
12.86
5 years 4.81
Extreme 4.81
16.09
10 years 4.81
Extreme 4.81
33.03
Manager TitleAgeSince
Chief Executive Officer 62 11/04/2006
Corporate Secretary 60 11/04/2006
Director TitleAgeSince
Chairman 62 11/04/2006
Director/Board Member 60 24/04/2009
Chairman 56 28/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
05/11/25 Buy

Director

100 0.0000%
29/10/25 Sell

Director

35,100 0.0041%
28/10/25 Sell

Director

340,000 0.0399%
Change 5-day change 1-year change 3-year change Capi.($)
-1.53%+3.41%-31.52%-55.02% 792M
-0.79%-4.48%+44.44%+127.49% 1,206B
+1.43%+1.11%+47.73%+82.08% 665B
+1.07%-1.21%+32.99%+106.31% 515B
-0.36%-3.25%+47.17%+64.58% 381B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 307B
-0.80%-0.21%+8.54%+35.56% 289B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 207B
Average -0.23%-1.23%+33.21%+63.40% 418.05B
Weighted average by Cap. -0.04%-1.96%+42.22%+88.35%

Financials

2024 2025
Net sales 660M 98.89M 88.69M 81.06M 73.99M 139M 9.3B 144M 977M 390M 4.96B 371M 363M 15.66B 624M 93.38M 83.76M 76.55M 69.87M 132M 8.78B 136M 923M 368M 4.68B 351M 343M 14.79B
Net income -74.07M -11.09M -9.95M -9.09M -8.3M -15.63M -1.04B -16.13M -110M -43.69M -556M -41.63M -40.74M -1.76B -347M -51.99M -46.63M -42.61M -38.9M -73.29M -4.89B -75.6M -514M -205M -2.61B -195M -191M -8.23B
Net Debt -1.98B -297M -266M -243M -222M -418M -27.9B -432M -2.93B -1.17B -14.89B -1.11B -1.09B -47B -1.14B -171M -153M -140M -128M -241M -16.07B -249M -1.69B -673M -8.57B -641M -628M -27.06B
Projected Income Statement - Annual - Beijing SL Pharmaceutical Co., Ltd.
Logo Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.
Employees
901
Date Price Change Volume
06/11/26 CN¥5.150 -1.53% 11,090,960
05/11/26 CN¥5.230 +1.55% 13,608,118
04/11/26 CN¥5.150 +1.18% 14,394,212
03/11/26 CN¥5.090 +0.39% 10,520,625
02/11/26 CN¥5.070 +1.81% 13,699,300

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing SL Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002038 Stock